Ipriflavone (Vietnamese Wikipedia)

Analysis of information sources in references of the Wikipedia article "Ipriflavone" in Vietnamese language version.

refsWebsite

Global rank Vietnamese rank

2^nd place

4^th place

7^th place

5^th place

13^th place

3^rd place

6^th place

books.google.com

Civitelli, R. (1997). “In Vitro and in Vivo effects of ipriflavone on bone formation and bone biomechanics”. Calcified Tissue International. 61: S12–4. doi:10.1007/s002239900378. PMID 9263610.
Alexandersen, P.; Toussaint, A; Christiansen, C; Devogelaer, JP; Roux, C; Fechtenbaum, J; Gennari, C; Reginster, JY; Ipriflavone Multicenter European Fracture Study (2001). “Ipriflavone in the Treatment of Postmenopausal Osteoporosis: A Randomized Controlled Trial”. JAMA. 285 (11): 1482–8. doi:10.1001/jama.285.11.1482. PMID 11255425.
Arjmandi, B. H.; Birnbaum, R. S.; Juma, S.; Barengolts, E.; Kukreja, S. C. (2000). “The Synthetic Phytoestrogen, Ipriflavone, and Estrogen Prevent Bone Loss by Different Mechanisms”. Calcified Tissue International. 66 (1): 61–65. doi:10.1007/s002230050012. ISSN 0171-967X.
Petilli, M.; Fiorelli, G.; Benvenuti, S.; Frediani, U.; Gori, F.; Brandi, M. L. (1995). “Interactions between ipriflavone and the estrogen receptor”. Calcified Tissue International. 56 (2): 160–165. doi:10.1007/BF00296349. ISSN 0171-967X.
Melis, Gian Benedetto; Paoletti, A. M.; Cagnacci, A.; Bufalino, L.; Spinetti, A.; Gambacciani, M.; Fioretti, P. (2014). “Lack of any estrogenic effect of ipriflavone in postmenopausal women”. Journal of Endocrinological Investigation. 15 (10): 755–761. doi:10.1007/BF03347647. ISSN 0391-4097. PMID 1491124.

Civitelli, R. (1997). “In Vitro and in Vivo effects of ipriflavone on bone formation and bone biomechanics”. Calcified Tissue International. 61: S12–4. doi:10.1007/s002239900378. PMID 9263610.
Alexandersen, P.; Toussaint, A; Christiansen, C; Devogelaer, JP; Roux, C; Fechtenbaum, J; Gennari, C; Reginster, JY; Ipriflavone Multicenter European Fracture Study (2001). “Ipriflavone in the Treatment of Postmenopausal Osteoporosis: A Randomized Controlled Trial”. JAMA. 285 (11): 1482–8. doi:10.1001/jama.285.11.1482. PMID 11255425.
Sziklai, I; Komora, V; Ribári, O (1992). “Double-blind study on the effectiveness of a bioflavonoid in the control of tinnitus in otosclerosis”. Acta Chirurgica Hungarica. 33 (1–2): 101–7. PMID 1343452.
Melis, Gian Benedetto; Paoletti, A. M.; Cagnacci, A.; Bufalino, L.; Spinetti, A.; Gambacciani, M.; Fioretti, P. (2014). “Lack of any estrogenic effect of ipriflavone in postmenopausal women”. Journal of Endocrinological Investigation. 15 (10): 755–761. doi:10.1007/BF03347647. ISSN 0391-4097. PMID 1491124.

Arjmandi, B. H.; Birnbaum, R. S.; Juma, S.; Barengolts, E.; Kukreja, S. C. (2000). “The Synthetic Phytoestrogen, Ipriflavone, and Estrogen Prevent Bone Loss by Different Mechanisms”. Calcified Tissue International. 66 (1): 61–65. doi:10.1007/s002230050012. ISSN 0171-967X.
Petilli, M.; Fiorelli, G.; Benvenuti, S.; Frediani, U.; Gori, F.; Brandi, M. L. (1995). “Interactions between ipriflavone and the estrogen receptor”. Calcified Tissue International. 56 (2): 160–165. doi:10.1007/BF00296349. ISSN 0171-967X.
Melis, Gian Benedetto; Paoletti, A. M.; Cagnacci, A.; Bufalino, L.; Spinetti, A.; Gambacciani, M.; Fioretti, P. (2014). “Lack of any estrogenic effect of ipriflavone in postmenopausal women”. Journal of Endocrinological Investigation. 15 (10): 755–761. doi:10.1007/BF03347647. ISSN 0391-4097. PMID 1491124.